product portfolio
What we do
APIs and Intermediates:
We are a specialized pharma company focusing on niche therapeutic areas of CNS, ARVs and controlled substances. Our specialization in unique CNS segments like ADHD, Anti-psychotics, Anti-vertigo, Anti-inflammatory, Pain management, Alzheimer disease and others gives ZCL the leverage to outclass the competition. We are moving up the value chain adding capacity for more APIs.

CMO:
With the best in class manufacturing facilities with accreditation and state-of-the-art research platform besides brilliant minds in our R&D we have embarked on establishing contract manufacturing organization. We have many on-going contract manufacturing projects that involve complex chemistry and technological excellence.

Active Pharma Ingredients (APIs)
Product Status Pharmacoepeia CAS No. Therapeutic Use Enquiry
Alprazolam Tech pack USP/EP 28981-97-7 Anxiolytic Enquire Now
Aripiprazole USDMF⁺, CEP, KDMF USP/EP 129722-12-9 Anti-depressant/Anti-psychotic Enquire Now
Atomoxetine HCl CEP, USDMF, TDMF, IDL* USP/EP 82248-59-7 Attention Deficit Hyperactivity Disorder (ADHD) Enquire Now
Betahistine Dihydrochloride CEP, TDMF, CA-DMF USP/BP/EP/IP 5579-84-0 Vertigo Enquire Now
Clozapine USDMF⁺, CEP*,CA-DMF USP/EP/IP 5786-21-0 Anti-psychotic Enquire Now
Dapagliflozin propanediol monohydrate Tech pack Inhouse 960404-48-2 Anti-diabetic Enquire Now
Darunavir ethanolate Tech pack Inhouse 635728-49-3 Treatment of AIDS and HIV infections Enquire Now
Dexmethylphenidate HCl Tech pack Inhouse 19262-68-1 Attention Deficit Hyperactivity Disorder (ADHD) Enquire Now
Empagliflozin Tech pack In-house 864070-44-0 Anti-diabetic Enquire Now
Eslicarbazepine Acetate USDMF*, EDMF* In-house/IP 236395-14-5 Anti-epileptic Enquire Now
Felbinac EDMF BP/EP/JP 5728-52-9 Anti-inflammatory Enquire Now
Fluvoxamine Maleate USDMF⁺,CEP, TDMF USP/BP/EP/IP 61718-82-9 Anti-depressant Enquire Now
Levomepromazine Maleate CEP* EP/JP 7104-38-3 Anti-psychotic Enquire Now
Lurasidone HCl USDMF In-house 367514-88-3 Anti-psychotic Enquire Now
Memantine HCl USDMF, AUSDMF USP/IP 41100-52-1 Alzheimer Disease Enquire Now
Methylphenidate HCl CEP USP/EP 298-59-9 Attention Deficit Hyperactivity Disorder (ADHD) Enquire Now
Mirabegron Tech pack In-house 223673-61-8 Treatment of overactive bladder Enquire Now
Modafinil Tech pack USP/EP 68693-11-8 CNS Stimulant Enquire Now
Olanzapine Tech pack USP 132539-06-1 Anti-psychotic Enquire Now
Phenylephrine hydrochloride Tech pack EP/IP 61-76-7 Decongestant Enquire Now
Pirfenidone USDMF*, CEP EP/IP 53179-13-8 Anti-Inflammatory / Anti-Rheumatic Enquire Now
Pregabalin Tech pack IP/USP/EP 148553-50-8 Epilepsy, Neuropathic pain and generalized anxiety disorder Enquire Now
Quetiapine Fumarate USDMF⁺, AUSDMF, CEP & KDMF USP/EP 111974-72-2 Anti-psychotic Enquire Now
Rivaroxaban USDMF In-house 366789-02-8 Anti-coagulant Enquire Now
Trifluoperazine HCl Tech pack USP/BP/EP/IP 440-17-5 Anti-psychotic Enquire Now
Zaltoprofen KDMF JP 74711-43-6 Anti-inflammatory Enquire Now
Zonisamide USDMF,JDMF* USP,JP 68291-97-4 Anti-convulsant Enquire Now
 
Product Pipeline / Under evaluation
Apixaban Under development In-house 503612-47-3 Anticoagulant Enquire Now
Dapsone Under development In-house 80-08-0 Anti fungal,Anti acne,Anti-leprosy Enquire Now
Ticagrelor Under development In-house 274693-27-5 Platelet aggregation inhibitor Enquire Now
Irbesartan Under evaluation In-house 138402-11-6 Antihypertensive Enquire Now
Olmesartan Under evaluation In-house 144689-63-4 Antihypertensive Enquire Now
Telmisartan Under evaluation In-house 144701-48-4 Antihypertensive Enquire Now
Trimebutine Maleate Under evaluation In-house 34140-59-5 Antimuscarinic Enquire Now
* Under filing, + DMF Info Available for Reference
Disclaimer:
All transactions are carried out in conformity with the patent laws applicable in the user country.
Responsibility with respect to third partie’s patent rights in a specific country lies exclusively with the buyer.
The therapeutic use shown against each product is indicative only and is not for advertising ZCL products.
Patented Products are available for R&D use as per permitted under 35 USC ¶ 271 (e) (1)

Advanced Intermediates
Product CAS No. End Use Structure Enquiry
1-(2,3-Dichlorophenyl) Piperazine HCl 119532-26-2 Aripiprazole Enquire Now
N-Benzhydrylpiperazine 841-77-0 Cinnarizine Enquire Now
Benzenesulfonamide, 4-amino-N-[(2R,3S)-3-amino-2- hydroxy-4-phenylbutyl]-N-(2-methylpropyl) 169280-56-2 Darunavir Enquire Now
Carbamic acid, N-[(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-1- (phenylmethyl)propyl]-,1,1-dimethylethylester 191226-98-9 Darunavir, Fosamprenavir Enquire Now
(10S)-10,11-Dihydro-10-hydroxy-5Hdibenz[b,f]azepine-5-carboxamide 104746-04-5 Eslicarbazepine acetate Enquire Now
10,11-Dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide 29331-92-8 Eslicarbazepine acetate Enquire Now
4,4'-Difluorobenzhydrylpiperazine 27469-60-9 Flunarizine Enquire Now
(1E)-N-Hydroxy-5-Methoxy-1-(4-Trifluoromethylphenyl)Pentan-1-Imine 61747-22-6 Fluvoxamine Enquire Now
2-Bromo-4'-benzyloxy-3'-nitroacetophenone 43229-01-2 Formoterol Enquire Now
2,4-Dihydro-4-[4-[4-(4-methoxyphenyl)-1- piperazinyl]phenyl]-2-(1-methyl propyl)-3H-1,2,4-triazol-3-one 252964-68-4 Itraconazole Enquire Now
1-Acetyl-4-(4-hydroxyphenyl) piperazine 67914-60-7 Ketoconazole Enquire Now
(1R)-2-{[2-(4-aminophenyl)ethyl]amino}-1-phenylethanol 391901-45-4 Mirabegron Enquire Now
(1R)-2-{[2-(4-nitrophenyl)ethyl]amino}-1-phenylethanol 223673-34-5 Mirabegron Enquire Now
2-Methyl-10H-thieno[2,3-b][1,5] benzo diazepine-4-amine HCl 138564-60-0 Olanzapine Enquire Now
5-methyl-2-(2-nitrophenylamino) thiophene-3-carbonitrile 138564-59-7 Olanzapine Enquire Now
5-methylpyridin-2(1H)-one (synonym : 2-Hydroxy-5-methylpyridine) 1003- 68-5 Pirfenidone Enquire Now
1-Aminoindan 34698-41-4 Rasagiline Enquire Now
4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one hydrochloride 898543-06-1 Rivaroxaban Enquire Now
2-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl) phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione 446292-08-6 Rivaroxaban Enquire Now
2-(Trifluoromethyl)-phenothiazine 92-30-8 Trifluoperazine Enquire Now
Disclaimer:
All transactions are carried out in conformity with the patent laws applicable in the user country.
Responsibility with respect to third partie’s patent rights in a specific country lies exclusively with the buyer.
The therapeutic use shown against each product is indicative only and is not for advertising ZCL products.
Patented Products are available for R&D use as per permitted under 35 USC ¶ 271 (e) (1)
Intermediate for controlled substances
Product CAS No. End Use Structure Enquiry
N-[1-(benzyl)-4-(methoxymethyl)-4-piperidinyl]-N-phenyl Propanamide oxalate 61086-13-3 Alfentanil & Sufentanil Enquire Now
N-[4-(methoxymethyl)-piperidine-4-yl]-N-phenylpropanamide monohydrochloride 84196-16-7 Alfentanil & Sufentanil Enquire Now
N-(1-Benzylpiperidin-4-yl)-N-phenylpropanamide Hydrochloride 5156-58-1 Fentanil Enquire Now
Methyl 4-(phenyl-propionyl-amino)-piperidine-4-carboxylate HCl 61085-87-8 Remifentanil Enquire Now
N-[(4-Methoxymethyl)-4-piperidinyl]-N-phenylpropanamide 61086-18-8 Sufentanil Enquire Now
Methyl Phenidate Series
Product CAS No. Structure Enquiry
Phenyl-(2-pyridyl acetamide) 7251-52-7 Enquire Now
Phenyl-2-(2'-piperidyl)acetamide 19395-39-2 Enquire Now
Threo phenyl-2-piperidyl acetamide* 50288-62-5 Enquire Now
dl-threo ritalinic acid* 54631-24-2 Enquire Now
dl-Threo-Ritalinic acid HCl 1382859-13-3 Enquire Now
d-threo ritalinic acid hydrohloride* 741705-70-4 Enquire Now
*USDMF available
Disclaimer:
All transactions are carried out in conformity with the patent laws applicable in the user country.
Responsibility with respect to third partie’s patent rights in a specific country lies exclusively with the buyer.
The therapeutic use shown against each product is indicative only and is not for advertising ZCL products.
Patented Products are available for R&D use as per permitted under 35 USC ¶ 271 (e) (1)
Under Scale-up / New Development
Product CAS No. End Use Status Structure Enquiry
4-Amino-2-fluoro-N-methylbenzamide 915087-25-1 Apalutamide,Enzalutamide Underscale-up Enquire Now
Ethyl 6-(4-iodophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate 473927-64-9 Apixaban Under scaleup Enquire Now
Ethyl 1-(4-Methoxyphenyl)-7-oxo-6(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate; 503614-91-3 Apixaban Under scaleup Enquire Now
3,3-dichloro-1-(4-iodophenyl)piperidin-2-one 545445-10-1 Apixaban Under scaleup Enquire Now
(5-Bromo-2-chloro-4'ethoxydiphenylmethane 461432-23-5 Dapagliflozin Under Scale-up Enquire Now
1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-,2,3,4,6-tetraacetate,(1S)-D-Glucitol 461432-25-7 Dapagliflozin propanediol Under development Enquire Now
2,3,4,6-tetra-O-trimethylsilyl-ß-D-glucolactone 32384-65-9 Dapagliflozin,Empagliflozin Under Scale-up Enquire Now
4,4'-sulfonylbis(nitrobenzene) 1156-50-9 Dapsone Under scale-up Enquire Now
Bis(4-nitrophenyl)sulfane 1223-31-0 Dapsone Under scale-up Enquire Now
(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran 915095-89-5 Empagliflozin Under development Enquire Now
(S)-(5-bromo-2-chlorophenyl)(4-((tetrahydrofuran-3-yl) oxy)phenyl)methanone 915095-84-0 Empagliflozin Under development Enquire Now
(5-bromo-2-chlorophenyl)(4-fluorophenylmethanone 915095-85-1 Empagliflozin Under development Enquire Now
(2R,3R,4R,5S,6S)-2- (acetoxymethyl)-6-(4-chloro- 3-(4-(((S)-tetrahydrofuran3-yl)oxy)benzyl)phenyl)tetrahy dro-2H-pyran-3,4,5-triyl triacetate 915095-99-7 Empagliflozin Under development Enquire Now
N-Methyl-2-fluoro-4-(1,1-dimethyl cyanomethyl)aminobenzamide 915087-32-0 Enzalutamide Under Scale-up Enquire Now
2-(((3aR,4S,3R,6aS)-6-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol 376608-74-1 Ticagrelor Under Scale-up Enquire Now
*USDMF available
Disclaimer:
All transactions are carried out in conformity with the patent laws applicable in the user country.
Responsibility with respect to third partie’s patent rights in a specific country lies exclusively with the buyer.
The therapeutic use shown against each product is indicative only and is not for advertising ZCL products.
Patented Products are available for R&D use as per permitted under 35 USC ¶ 271 (e) (1)

Disclaimer
Information given herein is offered in good faith as accurate, but without guarantee. Conditions of use and suitability of the product for particular uses are beyond our control. All risks of use of the product are therefore assumed by the user. ZCL Chemicals Limited EXPRESSLY DISCLAIMS ALL WARRANTIES OF EVERY KIND AND NATURE, INCLUDING WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE IN RESPECT TO THE USE OR SUITABILITY OF THE PRODUCT. Appropriate warnings and safe handling procedures should be provided to handlers and users.

Alteration of this document is strictly prohibited.

No statement contained herein concerning a possible or suggested use of any material, product or design is intended, or should be construed, to grant any license under any patent or other intellectual property right of ZCL Chemicals Limited or any of its associates or its affiliates covering such use or design, or as a recommendation for the use of such material, product or design in the infringement of any patent or other intellectual property right. The products are sold subject to ZCL Chemicals Limited Standard Conditions of Sale, which are available upon request.
Socialize with us